| Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State (NCT03705533) | Pharmtechnology LLC | 2018-09-07 |
| Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis (NCT03575780) | Athenex, Inc. | 2018-09-07 |
| Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects (NCT04319926) | Scilex Pharmaceuticals, Inc. | 2018-09-07 |
| Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies (NCT03588598) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2018-09-07 |
| Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers (NCT03641794) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2018-09-07 |
| Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer (NCT03667482) | Memorial Sloan Kettering Cancer Center | 2018-09-07 |
| Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR (NCT03676504) | University Hospital Heidelberg | 2018-09-07 |
| CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL. (NCT03671460) | Tianjin Mycure Medical Technology Co., Ltd | 2018-09-07 |
| Study to Evaluate the Abuse Potential of ACT-541468 in Healthy Recreational Drug Users (NCT03657355) | Idorsia Pharmaceuticals Ltd. | 2018-09-07 |
| IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors (NCT03665129) | Innate Pharma | 2018-09-07 |
| Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer (NCT03634150) | Immune System Key Ltd | 2018-09-06 |
| A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer (NCT03575793) | Salma Sabbour | 2018-09-06 |
| Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock (NCT03649633) | University of Athens | 2018-09-06 |
| An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy Participants (NCT03712540) | Bristol-Myers Squibb | 2018-09-06 |
| A Study of Two Formulations of LY3074828 in Healthy Participants (NCT03662100) | Eli Lilly and Company | 2018-09-06 |
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. (NCT03667716) | Compugen Ltd | 2018-09-06 |
| Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) (NCT03393884) | Imunon | 2018-09-05 |
| Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102 (NCT03679754) | Alaunos Therapeutics | 2018-09-05 |
| A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations (NCT03781934) | Medivir | 2018-09-05 |
| Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State (NCT03670082) | H. Lundbeck A/S | 2018-09-05 |
| Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes (NCT03635437) | Per-Ola Carlsson | 2018-09-05 |
| First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody (NCT03665155) | Memorial Sloan Kettering Cancer Center | 2018-09-05 |
| Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 (NCT03793985) | Chong Kun Dang Pharmaceutical | 2018-09-05 |
| NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) (NCT03399448) | University of Pennsylvania | 2018-09-05 |
| Oral Melatonin as Premedication During MAC for Patients Undergoing Loco-regional Chronic Subdural Hematoma Evacuation (NCT03732963) | Cairo University | 2018-09-05 |
| A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers (NCT03656952) | Pfizer | 2018-09-05 |
| APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC (NCT03655613) | Apollomics (Australia) Pty. Ltd. | 2018-09-05 |
| Recombinant SeV-hFGF2/dF Injection for PAOD (NCT03668353) | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2018-09-05 |
| A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants (NCT03649165) | AstraZeneca | 2018-09-05 |
| The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD (NCT03679312) | University of Alberta | 2018-09-04 |
| T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer (NCT03318900) | M.D. Anderson Cancer Center | 2018-09-04 |
| Pharmacokinetic Interactions of Metamizole (Dipyrone) in Healthy Subjects (NCT03990129) | University Hospital, Basel, Switzerland | 2018-09-04 |
| A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients (NCT04152148) | Bio-Thera Solutions | 2018-09-04 |
| Selumetinib and Azacitidine in High Risk Chronic Blood Cancers (NCT03326310) | University of Chicago | 2018-09-04 |
| Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection (NCT03674125) | GeneOne Life Science, Inc. | 2018-09-04 |
| A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate (NCT03740373) | AstraZeneca | 2018-09-04 |
| The Tolerability and Pharmacokinetics Study of HEC74647PA Capsule in Healthy Adult Subjects (NCT03673696) | Sunshine Lake Pharma Co., Ltd. | 2018-09-04 |
| Extremely Low Gestatonal Age Infants' Paracetamol Study (NCT03641209) | Outi Aikio | 2018-09-03 |
| Cycloserine rTMS Plasticity Augmentation in Depression (NCT03511599) | University of Calgary | 2018-09-03 |
| Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus (NCT03648437) | University of Oulu | 2018-09-03 |
| Bioequivalence of Imeglimin Tablet Formulations (NCT03646331) | Poxel SA | 2018-09-03 |
| OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma (NCT03587038) | University of Oklahoma | 2018-09-03 |
| Clinical Trial to Evaluate the Safety of PT150 (Formerly ORG34517) When it is Taken Concurrently With Alcohol (NCT03548714) | Pop Test Oncology LLC | 2018-09-01 |
| Hangover and Residual Zopiclone Effect on Spatial Perception (NCT03632408) | Petri Vainio | 2018-09-01 |
| Caudal Ketamine-bupivacaine More Effective Than Bupivacaine-saline (NCT05444036) | Egymedicalpedia | 2018-09-01 |
| Monthly Versus Two Doses of Ante-Natal Intermittent Preventive Treatment With Sulphadoxine-Pyrimethamine (NCT03599596) | University College Hospital, Ibadan | 2018-09-01 |
| Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AML (NCT03913312) | Ruijin Hospital | 2018-09-01 |
| Efficacy Comparison of Warfarin Versus Rivaroxaban CVT (NCT03747081) | Isfahan University of Medical Sciences | 2018-09-01 |
| The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis (NCT04697199) | Tanta University | 2018-09-01 |
| Bariatric Embolization Trial for the Obese Nonsurgical (NCT03601273) | University of Calgary | 2018-09-01 |
| Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas (NCT03417765) | GlyPharma Therapeutics | 2018-09-01 |
| Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas (NCT03187210) | Insel Gruppe AG, University Hospital Bern | 2018-09-01 |
| XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma (NCT03599778) | Anhui Provincial Hospital | 2018-09-01 |
| Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate) (NCT03575403) | Craig Rush | 2018-09-01 |
| A Phase Ib Combination Study of Rituximab, TinostamustinEAnd CHeckpoint Inhibition With Pembrolizumab in Relapsed/Refractory DLBCL (NCT04279938) | Royal Marsden NHS Foundation Trust | 2018-09-01 |
| HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer (NCT03578406) | Xinqiao Hospital of Chongqing | 2018-09-01 |
| Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy (NCT03331302) | University of Virginia | 2018-09-01 |
| 4FMFES-PET Imaging of Endometrial and Ovarian Cancers (NCT04823065) | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 2018-09-01 |
| NMDA Receptor Modulation for Hyperarousal in PTSD (NCT03166501) | Baylor College of Medicine | 2018-09-01 |
| A Neurosteroid Intervention for Menopausal and Perimenopausal Depression (NCT03505905) | University of Texas Southwestern Medical Center | 2018-09-01 |
| Effect of Different Skin Creams on TEWL (NCT03663673) | Stanford University | 2018-09-01 |
| Epacadostat, Idarubicin and Cytarabine (EIC) in AML (NCT03444649) | Insel Gruppe AG, University Hospital Bern | 2018-09-01 |
| Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals (NCT03595774) | Indiana University | 2018-09-01 |
| Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin (NCT03649113) | Tehran University of Medical Sciences | 2018-09-01 |
| An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer (NCT07271446) | Precision Biotech Taiwan Corp. | 2018-09-01 |
| Evaluation of Viatar™ Oncopheresis System in Removing CTC From Whole Blood (NCT03058809) | Viatar LLC | 2018-09-01 |
| Postoperative Ibuprofen Use and Risk of Bleeding in Pediatric Tonsillectomy (NCT03385057) | Massachusetts Eye and Ear Infirmary | 2018-09-01 |
| Radiofrequency, Perineural Injection, Idiopathic Carpal Tunnel Syndrome (NCT05053477) | Alexandria University | 2018-09-01 |
| Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy (NCT03577782) | Hospitales Universitarios Virgen del Rocío | 2018-09-01 |
| Detection of Hypoxia in Human Thoracic Aorta Using Pimonidazole Hydrochloride (NCT03410420) | Thomas Gleason | 2018-09-01 |
| Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers (NCT03668509) | Jiangsu HengRui Medicine Co., Ltd. | 2018-09-01 |
| Electrophysiological Biomarkers of AV-101 (NCT03583554) | Marijn Lijffijt, PhD | 2018-09-01 |
| The Safety and Efficacy of Deferoxamine for Treating Unresectable Hepatocellular Carcinoma (NCT03652467) | Jinan Military General Hospital | 2018-09-01 |
| QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. (NCT03647423) | ImmunityBio, Inc. | 2018-08-31 |
| Effects of Wild Blueberry Ingestion on Motor Performance of People With Parkinson's Disease (NCT07720869) | Louisiana State University, Baton Rouge | 2018-08-31 |
| BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) (NCT03496662) | Washington University School of Medicine | 2018-08-31 |
| A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects (NCT03726866) | Chong Kun Dang Pharmaceutical | 2018-08-31 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers (NCT03547037) | Janssen Pharmaceutical K.K. | 2018-08-31 |
| A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer (NCT03523442) | Janssen Research & Development, LLC | 2018-08-31 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963) | M.D. Anderson Cancer Center | 2018-08-31 |
| First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect (NCT03627494) | GlaxoSmithKline | 2018-08-30 |
| Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects (NCT04762355) | Clementia Pharmaceuticals Inc. | 2018-08-30 |
| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) (NCT03563326) | Jian-Kun Hu | 2018-08-30 |
| Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma (NCT03590574) | Autolus Limited | 2018-08-30 |
| Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults (NCT03646799) | Chong Kun Dang Pharmaceutical | 2018-08-30 |
| The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects (NCT03634436) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-30 |
| Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma (NCT03302728) | Peter MacCallum Cancer Centre, Australia | 2018-08-30 |
| A Study of LY3316531 in Healthy Participants (NCT03611608) | Eli Lilly and Company | 2018-08-30 |
| Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17) (NCT03643549) | Haukeland University Hospital | 2018-08-30 |
| Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration (NCT05975892) | Instituto Venezolano de Investigaciones Cientificas | 2018-08-30 |
| IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT (NCT03696537) | Naoyuki G. Saito, M.D., Ph.D. | 2018-08-29 |
| RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration (NCT03633084) | Ribomic USA Inc | 2018-08-29 |
| Efficacy of Ginger Extract (Compare Between the Ginger Preparation of Ancient Concept of Thai Traditional Practitioner, Standard Drug and Placebo) by Using Pain Score to Evaluate After Pain of Three Groups of First Normal Postpartum Women. (NCT03617900) | Thammasat University | 2018-08-29 |
| A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS (NCT03593915) | Sumitomo Pharma America, Inc. | 2018-08-29 |
| Spinal Cord Stimulation for the Treatment of Major Depressive Disorder (NCT03433339) | University of Cincinnati | 2018-08-29 |
| Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (NCT03608696) | Thomas Jefferson University | 2018-08-29 |
| Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age (NCT03642847) | Pfizer | 2018-08-29 |
| A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors (NCT03611868) | Ascentage Pharma Group Inc. | 2018-08-29 |
| A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer. (NCT03681548) | Ayana Pharma Ltd., | 2018-08-29 |
| Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine (NCT03633110) | Genocea Biosciences, Inc. | 2018-08-29 |